BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 8, 2004
View Archived Issues
Senate Hearing Discusses Pros, Cons Of BioShield II
Read More
Acuity Pharmaceuticals Touts RNAi Trial As Historic First'
Read More
FDA Puts TNFerade On Hold; GenVec Stock Takes Nosedive
Read More
rAAT Phase II Study Misses In Atopic Dermatitis; ProMetic Falls
Read More
Other News To Note
Read More
Theravance Prices $98M IPO; Three Others Raise $85M Total
The first full week of October proved to be a busy one for financings in the biotechnology world. (BioWorld Today)
Read More
Genentech's 3Q Earnings Top Consensus Estimates
Read More